| 1/10 | US=15 / Gastro Philip PA, Heilbrun LK, Abrams J. Pitfalls in clinical trial and future directions. In: Lowy AM, Leach SD, Philip PA. Pancreatic cancer. New York: Springer, 2008. p. 723-31. ISBN 978-0-387-69250-0. |
| 2/10 | US=58 / Câncer Zhang H, Xiao Z, Sowin T. ChK1 and ChK2 as checkpoint targets. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 245-59. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. CHK1; CHK2; INIBIDORES; PARADA DO CICLO CELULAR; REVOGACAO DA RESPOSTA CHECKPOINT; CHEMOPROTECTION; BIOMARCADORES PREDITIVOS |
| 3/10 | US=2 / Mama Duffy MJ. Tissue predictive biomakers: urokinase-type plasminogen activator and PAI-1. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 111-28. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; UROQUINASE; PLASMINOGENIO; PAI-1; CANCER; MARCADORES TUMORAIS; CANCER DE MAMA |
| 4/10 | US=2 / Mama Duffy MJ. Tissue predictive biomakers: predictive value of c-erb-B2 for endocrine therapy and chemotherapy in breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 129-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; VALOR PREDITIVO DE C-ERB-B2; HORMONIOTERAPIA; QUIMIOTERAPIA; CANCER DE MAMA; TRASTUZUMABE |
| 5/10 | US=2 / Mama Mass R. Tissue predictive biomakers: erb-B2 as a therapeutic target. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 159-75. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; ERB-B2; ALVO TERAPEUTICO; CANCER DE MAMA; HER2; TRASTUZUMABE; ANTICORPOS MONOCLONAIS |
| 6/10 | US=2 / Mama Kandioler D, Jakesk R. Tissue predictive biomakers: p53 as a prognostic and predicitive indicator. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 193-209. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. |
| 7/10 | US=2 / Mama Braun S, Seeber J, Marth C. Predictive biomarkers in body fluids: occult metastatic cells in breast cancer patients. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 213-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CELULAS METASTATICAS; CANCER DE MAMA; PROGNOSTICO |
| 8/10 | US=2 / Mama Lipton A, Demmers L, Leitzel K, Ali SM, Neumann R, Price CP, Carney WP. Predictive biomarkers in body fluids: circulating HER2/neu: clinical utility. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 235-65. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CIRCULACAO HER2/NEU; ONCOPROTEINA; CANCER DE MAMA |
| 9/10 | US=2 / Mama Sarmiento R, Franceschini R, Meo S, Gion M, Longo R, Gaspirini G. Predictive biomarkers in body fluids: circulating vascular endothelial growth factor. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 267-92. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; CIRCULACAO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; CANCER DE MAMA; ANGIOGENESE; TERAPIA; PROGNOSTICO |
| 10/10 | US=2 / Mama Hawes D, Cote RJ. Predictive biomarkers in body fluids: detection of early tumor dissemination in patients with breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 293-321. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; FLUIDOS CORPORAIS; DETECCAO DE DISSEMINACAO DO TUMOR PRECOCE; CANCER DE MAMA; MEDULA OSSEA; CELULAS TUMORAIS CIRCULANTES; DISSEMINACAO DO TUMOR NO INICIO; CITOMETRIA DE FLUXO; IMUNO-HISTOQUIMICA; SEPARACAO IMUNO-MAGNETICA; LINFONODOS; MICROMETASTASES; METASTASES OCULTAS; SANGUE PERIFERICO; REACAO REVERSA DA CADEIA DE TRANSCRIPTASE-POLIMERASE; LINFONODO SENTINELA |